Parkinson's disease beyond 20 years.

Parkinson's disease beyond 20 years.

Item
http://www.wikidata.org/entity/Q43815096
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's DiseaseMissing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients.The role of prefrontal cortex during postural control in Parkinsonian syndromes a functional near-infrared spectroscopy study.Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan.Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.Dynamics of change in self-reported disability among persons with Parkinson's disease after 2 years of follow-up.Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of NeurolImpact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease
P2860

Parkinson's disease beyond 20 years.

Item
http://www.wikidata.org/entity/Q43815096
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Parkinson's disease beyond 20 years.
@en
Parkinson's disease beyond 20 years.
@nl
type
label
Parkinson's disease beyond 20 years.
@en
Parkinson's disease beyond 20 years.
@nl
prefLabel
Parkinson's disease beyond 20 years.
@en
Parkinson's disease beyond 20 years.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Parkinson's disease beyond 20 years.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921